Works matching IS 02704137 AND DT 2021 AND VI 81 AND IP 6

Results: 7

Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation.
Published in:
Prostate, 2021, v. 81, n. 6, p. 347, doi. 10.1002/pros.24113
By:
- Zheng, Xiaonan;
- Xu, Hang;
- Gong, Lina;
- Cao, Dehong;
- Jin, Tao;
- Wang, Yan;
- Pi, Jinkui;
- Yang, Yang;
- Yi, Xianyanling;
- Liao, Dazhou;
- Jin, Xi;
- Wei, Qiang;
- Yang, Lu;
- Li, Hong;
- Ai, Jianzhong
Publication type:
Article
The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients.
Published in:
Prostate, 2021, v. 81, n. 6, p. 339, doi. 10.1002/pros.24112
By:
- Wenzel, Mike;
- Würnschimmel, Christoph;
- Nocera, Luigi;
- Collà Ruvolo, Claudia;
- Tian, Zhe;
- Shariat, Shahrokh F.;
- Saad, Fred;
- Briganti, Alberto;
- Graefen, Markus;
- Kluth, Luis A.;
- Mandel, Philipp;
- Chun, Felix K. H.;
- Karakiewicz, Pierre I.
Publication type:
Article
Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer.
Published in:
Prostate, 2021, v. 81, n. 6, p. 318, doi. 10.1002/pros.24109
By:
- Leon, Priscilla;
- Cancel‐Tassin, Geraldine;
- Bourdon, Violaine;
- Buecher, Bruno;
- Oudard, Stephane;
- Brureau, Laurent;
- Jouffe, Lionel;
- Blanchet, Pascal;
- Stoppa‐Lyonnet, Dominique;
- Coulet, Florence;
- Sobol, Hagay;
- Cussenot, Olivier
Publication type:
Article
SEMA3C induces androgen synthesis in prostatic stromal cells through paracrine signaling.
Published in:
Prostate, 2021, v. 81, n. 6, p. 309, doi. 10.1002/pros.24107
By:
- Yenki, Parvin;
- Adomat, Hans H.;
- Ong, Christopher J.
Publication type:
Article
Issue Information.
Published in:
Prostate, 2021, v. 81, n. 6, p. 307, doi. 10.1002/pros.24004
Publication type:
Article
Molecular profiling of ETS and non‐ETS aberrations in prostate cancer patients from northern India.
Published in:
Prostate, 2021, v. 81, n. 6, p. 357, doi. 10.1002/pros.24111
By:
- Ateeq, B;
- Kunju, LP;
- Carskadon, SL;
- Pandey, SK;
- Singh, G;
- Pradeep, I;
- Tandon, V;
- Singhai, A;
- Goel, A;
- Amit, S;
- Agarwal, A;
- Dinda, AK;
- Seth, A;
- Tsodikov, A;
- Chinnaiyan, AM;
- Palanisamy, N
Publication type:
Article
Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial.
Published in:
Prostate, 2021, v. 81, n. 6, p. 326, doi. 10.1002/pros.24110
By:
- Shenderov, Eugene;
- Boudadi, Karim;
- Fu, Wei;
- Wang, Hao;
- Sullivan, Rana;
- Jordan, Alice;
- Dowling, Donna;
- Harb, Rana;
- Schonhoft, Joseph;
- Jendrisak, Adam;
- Carducci, Michael A.;
- Eisenberger, Mario A.;
- Eshleman, James R.;
- Luo, Jun;
- Drake, Charles G.;
- Pardoll, Drew M.;
- Antonarakis, Emmanuel S.
Publication type:
Article

Works matching IS 02704137 AND DT 2021 AND VI 81 AND IP 6

Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation.

The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients.

Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer.

SEMA3C induces androgen synthesis in prostatic stromal cells through paracrine signaling.

Issue Information.

Molecular profiling of ETS and non‐ETS aberrations in prostate cancer patients from northern India.

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial.